BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang J, Yang J, Zuo T, Ma S, Xokrat N, Hu Z, Wang Z, Xu R, Wei Y, Shen Q. Heparanase-driven sequential released nanoparticles for ferroptosis and tumor microenvironment modulations synergism in breast cancer therapy. Biomaterials 2021;266:120429. [PMID: 33035717 DOI: 10.1016/j.biomaterials.2020.120429] [Cited by in Crossref: 41] [Cited by in F6Publishing: 53] [Article Influence: 13.7] [Reference Citation Analysis]
Number Citing Articles
1 Li Q, Liu X, Yan C, Zhao B, Zhao Y, Yang L, Shi M, Yu H, Li X, Luo K. Polysaccharide-Based Stimulus-Responsive Nanomedicines for Combination Cancer Immunotherapy. Small 2023;:e2206211. [PMID: 36890780 DOI: 10.1002/smll.202206211] [Reference Citation Analysis]
2 Pan QF, Ouyang WW, Zhang MQ, He S, Yang SY, Zhang J. Chondroitin polymerizing factor predicts a poor prognosis and promotes breast cancer progression via the upstream TGF-β1/SMAD3 and JNK axis activation. J Cell Commun Signal 2023;17:89-102. [PMID: 36042157 DOI: 10.1007/s12079-022-00684-0] [Reference Citation Analysis]
3 Yin W, Chang J, Sun J, Zhang T, Zhao Y, Li Y, Dong H. Nanomedicine-mediated ferroptosis targeting strategies for synergistic cancer therapy. J Mater Chem B 2023;11:1171-90. [PMID: 36650960 DOI: 10.1039/d2tb02161g] [Reference Citation Analysis]
4 Yu X, Yang Y, Chen T, Wang Y, Guo T, Liu Y, Li H, Yang L. Cell death regulation in myocardial toxicity induced by antineoplastic drugs. Front Cell Dev Biol 2023;11:1075917. [PMID: 36824370 DOI: 10.3389/fcell.2023.1075917] [Reference Citation Analysis]
5 Sengupta S, Das P, Sharma S, Shukla MK, Kumar R, Kumar Tonk R, Pandey S, Kumar D. Role and Application of Biocatalysts in Cancer Drug Discovery. Catalysts 2023;13:250. [DOI: 10.3390/catal13020250] [Reference Citation Analysis]
6 Ma S, Liang X, Yang N, Yang J, Zhang J, Pan X, Wei Y, Liu Z, Shen Q. Boosting cancer immunotherapy by biomineralized nanovaccine with ferroptosis-inducing and photothermal properties. Biomater Sci 2023;11:518-32. [PMID: 36468623 DOI: 10.1039/d2bm01126c] [Reference Citation Analysis]
7 Yang F, Xiao Y, Ding JH, Jin X, Ma D, Li DQ, Shi JX, Huang W, Wang YP, Jiang YZ, Shao ZM. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy. Cell Metab 2023;35:84-100.e8. [PMID: 36257316 DOI: 10.1016/j.cmet.2022.09.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
8 Lin J, Yang H, Zhang Y, Zou F, He H, Xie W, Zou Z, Liu R, Xu Q, Zhang J, Zhong G, Li Y, Tang Z, Deng Y, Cai S, Wang L, Huang Y, Zhuo Y, Jiang X, Zhong W. Ferrocene-Based Polymeric Nanoparticles Carrying Doxorubicin for Oncotherapeutic Combination of Chemotherapy and Ferroptosis. Small 2023;19:e2205024. [PMID: 36398604 DOI: 10.1002/smll.202205024] [Reference Citation Analysis]
9 Yin C, Li Y, Liao Z, Wang Z, Dai C, Wang W, Yang E, Guo F, Wright IR, Martin LL, Sun D. Live bio-nano-sonosensitizer targets malignant tumors in synergistic therapy. Acta Biomater 2023;155:491-506. [PMID: 36427685 DOI: 10.1016/j.actbio.2022.11.037] [Reference Citation Analysis]
10 Yang L, Nao J. Ferroptosis: a potential therapeutic target for Alzheimer’s disease. Reviews in the Neurosciences 2022;0. [DOI: 10.1515/revneuro-2022-0121] [Reference Citation Analysis]
11 Ling YY, Wang WJ, Hao L, Wu XW, Liang JH, Zhang H, Mao ZW, Tan CP. Self-Amplifying Iridium(III) Photosensitizer for Ferroptosis-Mediated Immunotherapy Against Transferrin Receptor-Overexpressing Cancer. Small 2022;18:e2203659. [PMID: 36310137 DOI: 10.1002/smll.202203659] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhang X, Ge H, Ma Y, Song L, Ma Y, Tian G, Wang L, Meng Q, Sun X. Engineered Anti-cancer Nanomedicine for Synergistic Ferroptosis-Immunotherapy. Chemical Engineering Journal 2022. [DOI: 10.1016/j.cej.2022.140688] [Reference Citation Analysis]
13 Zhou X, Zhang J, Lv W, Zhao C, Xia Y, Wu Y, Zhang Q. The pleiotropic roles of adipocyte secretome in remodeling breast cancer. J Exp Clin Cancer Res 2022;41:203. [DOI: 10.1186/s13046-022-02408-z] [Reference Citation Analysis]
14 Ma X, Cai D, Zhang Z, Dai Q, Li X, Yu B, Ge B, Liu S, Wang X, Huang F. Peptidomimetic-liganded gold nanoclusters for controlled iron delivery and synergistic suppression of tumor growth. Nano Res 2022. [DOI: 10.1007/s12274-022-5103-y] [Reference Citation Analysis]
15 Qi X, Wan Z, Jiang B, Ouyang Y, Feng W, Zhu H, Tan Y, He R, Xie L, Li Y. Inducing ferroptosis has the potential to overcome therapy resistance in breast cancer. Front Immunol 2022;13:1038225. [PMID: 36505465 DOI: 10.3389/fimmu.2022.1038225] [Reference Citation Analysis]
16 Liu Y, Hu Y, Jiang Y, Bu J, Gu X. Targeting ferroptosis, the achilles’ heel of breast cancer: A review. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1036140] [Reference Citation Analysis]
17 Yang F, Wei P, Yang M, Chen W, Zhao B, Li W, Wang J, Qiu L, Chen J. Redox-sensitive hyaluronic acid-ferrocene micelles delivering doxorubicin for enhanced tumor treatment by synergistic chemo/chemodynamic therepay. Journal of Drug Delivery Science and Technology 2022;77:103851. [DOI: 10.1016/j.jddst.2022.103851] [Reference Citation Analysis]
18 Liang Y, Wang Y, Zhang Y, Ye F, Luo D, Li Y, Jin Y, Han D, Wang Z, Chen B, Zhao W, Wang L, Chen X, Ma T, Kong X, Yang Q. HSPB1 facilitates chemoresistance through inhibiting ferroptotic cancer cell death and regulating NF-κB signaling pathway in breast cancer.. [DOI: 10.1101/2022.10.25.513668] [Reference Citation Analysis]
19 Zhang M, Liu Z, Le Y, Gu Z, Zhao H. Iron-Sulfur Clusters: A Key Factor of Regulated Cell Death in Cancer. Oxidative Medicine and Cellular Longevity 2022;2022:1-15. [DOI: 10.1155/2022/7449941] [Reference Citation Analysis]
20 Zhang D, Sun Y, Wang S, Zou Y, Zheng M, Shi B. Brain‐Targeting Metastatic Tumor Cell Membrane Cloaked Biomimetic Nanomedicines Mediate Potent Chemodynamic and RNAi Combinational Therapy of Glioblastoma. Adv Funct Materials. [DOI: 10.1002/adfm.202209239] [Reference Citation Analysis]
21 Xie Z, Zhou Q, Qiu C, Zhu D, Li K, Huang H. Inaugurating a novel adjuvant therapy in urological cancers: Ferroptosis. Cancer Pathogenesis and Therapy 2022. [DOI: 10.1016/j.cpt.2022.10.002] [Reference Citation Analysis]
22 Chen X, Zhang X, Wu Y, Chen Y, Guo Y, Jana D, Wang D, Yuan W, Zhao Y. Tumor extracellular matrix-targeted nanoscavengers reverse suppressive microenvironment for cocktail therapy. Materials Today 2022. [DOI: 10.1016/j.mattod.2022.10.018] [Reference Citation Analysis]
23 Wang Y, Yi Y, Yao J, Wan H, Yu M, Ge L, Zeng X, Wu M, Mei L. Isoginkgetin Synergizes with Doxorubicin for Robust Co-delivery to Induce Autophagic Cell Death in Hepatocellular Carcinoma. Acta Biomater 2022:S1742-7061(22)00597-9. [PMID: 36152910 DOI: 10.1016/j.actbio.2022.09.035] [Reference Citation Analysis]
24 Li C, Li Y, Li G, Wu S. Functional Nanoparticles for Enhanced Cancer Therapy. Pharmaceutics 2022;14:1682. [PMID: 36015307 DOI: 10.3390/pharmaceutics14081682] [Reference Citation Analysis]
25 Feng W, Shi W, Wang Z, Cui Y, Shao X, Liu S, Rong L, Liu Y, Zhang H. Enhancing Tumor Therapy of Fe(III)-Shikonin Supramolecular Nanomedicine via Triple Ferroptosis Amplification. ACS Appl Mater Interfaces 2022. [PMID: 35944147 DOI: 10.1021/acsami.2c11130] [Reference Citation Analysis]
26 Zhang Z, Pan Y, Cun JE, Li J, Guo Z, Pan Q, Gao W, Pu Y, Luo K, He B. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy. Acta Biomater 2022:S1742-7061(22)00459-7. [PMID: 35926781 DOI: 10.1016/j.actbio.2022.07.055] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
27 Xu W, Qian J, Hou G, Wang T, Wang J, Wang Y, Yang L, Cui X, Suo A. A Hollow Amorphous Bimetal Organic Framework for Synergistic Cuproptosis/Ferroptosis/Apoptosis Anticancer Therapy via Disrupting Intracellular Redox Homeostasis and Copper/Iron Metabolisms. Adv Funct Materials. [DOI: 10.1002/adfm.202205013] [Reference Citation Analysis]
28 Li L, Wang B, Zhang Q, Song P, Jiang T, Zhao X. Hypoxia responsive fucoidan-based micelles for oxidative stress-augmented chemotherapy. European Polymer Journal 2022. [DOI: 10.1016/j.eurpolymj.2022.111340] [Reference Citation Analysis]
29 Xu W, Wang T, Qian J, Wang J, Hou G, Wang Y, Cui X, Suo A, Wu D. Fe(II)-hydrazide coordinated all-active metal organic framework for photothermally enhanced tumor penetration and ferroptosis-apoptosis synergistic therapy. Chemical Engineering Journal 2022;437:135311. [DOI: 10.1016/j.cej.2022.135311] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
30 Wang Y, Zhang J, Zhao Y, Pu M, Song X, Yu L, Yan X, Wu J, He Z. Innovations and challenges of polyphenol-based smart drug delivery systems. Nano Res . [DOI: 10.1007/s12274-022-4430-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Zhu L, Meng D, Wang X, Chen X. Ferroptosis-Driven Nanotherapeutics to Reverse Drug Resistance in Tumor Microenvironment. ACS Appl Bio Mater 2022. [PMID: 35614872 DOI: 10.1021/acsabm.2c00199] [Reference Citation Analysis]
32 Wang W, Fu F, Huang Z, Wang W, Chen M, Yue X, Fu J, Feng X, Huang Y, Wu C, Pan X. Inhalable Biomimetic Protein Corona-Mediated Nanoreactor for Self-Amplified Lung Adenocarcinoma Ferroptosis Therapy. ACS Nano 2022. [PMID: 35575209 DOI: 10.1021/acsnano.2c02634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Zhang N, Shu G, Qiao E, Xu X, Shen L, Lu C, Chen W, Fang S, Yang Y, Song J, Zhao Z, Tu J, Xu M, Chen M, Du Y, Ji J. DNA-Functionalized Liposomes In Vivo Fusion for NIR-II/MRI Guided Pretargeted Ferroptosis Therapy of Metastatic Breast Cancer. ACS Appl Mater Interfaces 2022;14:20603-15. [PMID: 35476429 DOI: 10.1021/acsami.2c01105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Wang Y, Zhong D, Xie F, Chen S, Ma Z, Yang X, Iqbal MZ, Zhang Q, Lu J, Wang S, Zhao R, Kong X. Manganese Phosphate-Doxorubicin-Based Nanomedicines Using Mimetic Mineralization for Cancer Chemotherapy. ACS Biomater Sci Eng 2022;8:1930-41. [PMID: 35380774 DOI: 10.1021/acsbiomaterials.2c00011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
35 Hou M, Zhu K, Hu H, Zheng S, Wu Z, Ren Y, Wu B, Qi L, Wu D, Xu Y, Yan C, Zhao B. Rapid synthesis of 'yolk-shell'-like nanosystem for MR molecular and chemo-radio sensitization. J Control Release 2022;347:55-67. [PMID: 35489546 DOI: 10.1016/j.jconrel.2022.04.033] [Reference Citation Analysis]
36 Ruan L, Zhang S, Chen X, Liang W, Xie Q. Role of Anti-Angiogenic Factors in the Pathogenesis of Breast Cancer: A Review of Therapeutic Potential. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.153956] [Reference Citation Analysis]
37 Zhu G, Chi H, Liu M, Yin Y, Diao H, Liu Z, Guo Z, Xu W, Xu J, Cui C, Xing XJ, Ma K. Multifunctional "ball-rod" Janus nanoparticles boosting Fenton reaction for ferroptosis therapy of non-small cell lung cancer. J Colloid Interface Sci 2022;621:12-23. [PMID: 35447518 DOI: 10.1016/j.jcis.2022.04.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Shi Z, Zheng J, Tang W, Bai Y, Zhang L, Xuan Z, Sun H, Shao C. Multifunctional Nanomaterials for Ferroptotic Cancer Therapy. Front Chem 2022;10:868630. [DOI: 10.3389/fchem.2022.868630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Jiang X, Zeng F, Yang X, Jian C, Zhang L, Yu A, Lu A. Injectable self-healing cellulose hydrogel based on host-guest interactions and acylhydrazone bonds for sustained cancer therapy. Acta Biomater 2022;141:102-13. [PMID: 34990813 DOI: 10.1016/j.actbio.2021.12.036] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
40 Giordo R, Wehbe Z, Paliogiannis P, Eid AH, Mangoni AA, Pintus G. Nano-targeting vascular remodeling in cancer: Recent developments and future directions. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.03.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
41 Zhao L, Zhou X, Xie F, Zhang L, Yan H, Huang J, Zhang C, Zhou F, Chen J, Zhang L. Ferroptosis in cancer and cancer immunotherapy. Cancer Communications 2022;42:88-116. [DOI: 10.1002/cac2.12250] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 20.0] [Reference Citation Analysis]
42 Zhu L, Chen M, Huang B, Zhang T, Chen K, Lian H, Liu M, Zhao K, Pang Y, Zhang J, Li Q, Zhong C. Genomic Analysis Uncovers Immune Microenvironment Characteristics and Drug Sensitivity of Ferroptosis in Breast Cancer Brain Metastasis. Front Genet 2022;12:819632. [DOI: 10.3389/fgene.2021.819632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Zhang Z, Ji Y, Lin C, Tao L. Thermosensitive hydrogel-functionalized gold nanorod/mesoporous MnO2 nanoparticles for tumor cell-triggered drug delivery. Mater Sci Eng C Mater Biol Appl 2021;131:112504. [PMID: 34857290 DOI: 10.1016/j.msec.2021.112504] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Ma X, Wang X, Liu C, Ge B, He H, Dai Q, Zhang Z, Yu J, Nau WM, Huang F. Self-assembled theranostic microcarrier targeting tumor cells with high metastatic potential. Materials & Design 2021;212:110196. [DOI: 10.1016/j.matdes.2021.110196] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Tao J, Li C, Zheng Y, Wang F, Zhang M, Wu X, Chen Y, Zeng Q, Chen F, Fei W. Biological protein mediated ferroptotic tumor nanotherapeutics. J Mater Chem B 2021;9:9262-84. [PMID: 34730601 DOI: 10.1039/d1tb01289d] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Guan Q, Zhou LL, Dong YB. Ferroptosis in cancer therapeutics: a materials chemistry perspective. J Mater Chem B 2021;9:8906-36. [PMID: 34505861 DOI: 10.1039/d1tb01654g] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
47 Zhou QM, Lu YF, Zhou JP, Yang XY, Wang XJ, Yu JN, Du YZ, Yu RS. Self-amplification of oxidative stress with tumour microenvironment-activatable iron-doped nanoplatform for targeting hepatocellular carcinoma synergistic cascade therapy and diagnosis. J Nanobiotechnology 2021;19:361. [PMID: 34749740 DOI: 10.1186/s12951-021-01102-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
48 Jia C, Guo Y, Wu FG. Chemodynamic Therapy via Fenton and Fenton-Like Nanomaterials: Strategies and Recent Advances. Small 2021;:e2103868. [PMID: 34729913 DOI: 10.1002/smll.202103868] [Cited by in Crossref: 35] [Cited by in F6Publishing: 43] [Article Influence: 17.5] [Reference Citation Analysis]
49 Zhou L, Chen J, Li R, Wei L, Xiong H, Wang C, Chai K, Chen M, Zhu Z, Yao T, Lin Y, Dong C, Shi S. Metal-Polyphenol-Network Coated Prussian Blue Nanoparticles for Synergistic Ferroptosis and Apoptosis via Triggered GPX4 Inhibition and Concurrent In Situ Bleomycin Toxification. Small 2021;17:e2103919. [PMID: 34623753 DOI: 10.1002/smll.202103919] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
50 Yang B, Chen Q. Cross-Talk between Oxidative Stress and m6A RNA Methylation in Cancer. Oxid Med Cell Longev 2021;2021:6545728. [PMID: 34484567 DOI: 10.1155/2021/6545728] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
51 Xu J, Jia Y, Liu M, Gu X, Li P, Fan Y. Preparation of Magnetic-Luminescent Bifunctional Rapeseed Pod-Like Drug Delivery System for Sequential Release of Dual Drugs. Pharmaceutics 2021;13:1116. [PMID: 34452077 DOI: 10.3390/pharmaceutics13081116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Xin X, Zhang Z, Zhang X, Chen J, Lin X, Sun P, Liu X. Bioresponsive nanomedicines based on dynamic covalent bonds. Nanoscale 2021;13:11712-33. [PMID: 34227639 DOI: 10.1039/d1nr02836g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Yang Z, Zhu Y, Dong Z, Li W, Yang N, Wang X, Feng L, Liu Z. Tumor-killing nanoreactors fueled by tumor debris can enhance radiofrequency ablation therapy and boost antitumor immune responses. Nat Commun 2021;12:4299. [PMID: 34262038 DOI: 10.1038/s41467-021-24604-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 16.0] [Reference Citation Analysis]
54 Wang Y, Chen H, Wei X. Circ_0007142 downregulates miR-874-3p-mediated GDPD5 on colorectal cancer cells. Eur J Clin Invest 2021;51:e13541. [PMID: 33797091 DOI: 10.1111/eci.13541] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
55 Xin J, Deng C, Aras O, Zhou M, Wu C, An F. Chemodynamic nanomaterials for cancer theranostics. J Nanobiotechnology 2021;19:192. [PMID: 34183023 DOI: 10.1186/s12951-021-00936-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 11.5] [Reference Citation Analysis]
56 Zhao Q, Jiang D, Sun X, Mo Q, Chen S, Chen W, Gui R, Ma X. Biomimetic nanotherapy: core-shell structured nanocomplexes based on the neutrophil membrane for targeted therapy of lymphoma. J Nanobiotechnology 2021;19:179. [PMID: 34120620 DOI: 10.1186/s12951-021-00922-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
57 Zhang J, Song L, Xu L, Fan Y, Wang T, Tian W, Ju J, Xu H. Knowledge Domain and Emerging Trends in Ferroptosis Research: A Bibliometric and Knowledge-Map Analysis. Front Oncol 2021;11:686726. [PMID: 34150654 DOI: 10.3389/fonc.2021.686726] [Cited by in Crossref: 20] [Cited by in F6Publishing: 27] [Article Influence: 10.0] [Reference Citation Analysis]
58 Zuo T, Zhang J, Yang J, Xu R, Hu Z, Wang Z, Deng H, Shen Q. On-demand responsive nanoplatform mediated targeting of CAFs and down-regulating mtROS-PYK2 signaling for antitumor metastasis. Biomater Sci 2021;9:1872-85. [PMID: 33464242 DOI: 10.1039/d0bm01878c] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
59 Zhang H, Ge Z, Wang Z, Gao Y, Wang Y, Qu X. Circular RNA RHOT1 promotes progression and inhibits ferroptosis via mir-106a-5p/STAT3 axis in breast cancer. Aging (Albany NY) 2021;13:8115-26. [PMID: 33686957 DOI: 10.18632/aging.202608] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 12.5] [Reference Citation Analysis]